HomeInsightsPE

Kilitch Drugs (india) Ltd PE Ratio

Kilitch Drugs (india) Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 13, 2024)

stocks purchased

0.9 K

Stocks Traded

(Dec 13, 2024)

Last Updated on: Dec 14, 2024

Image

Kilitch Drugs (India) Ltd

NSE: KILITCH

PE

31.9

Last updated on: Dec 14, 2024

Key Highlights

  • The P/E Ratio of Kilitch Drugs (India) Ltd is 31.9 as of 14 Dec 15:30 PM .
  • The P/E Ratio of Kilitch Drugs (India) Ltd changed from 79.4 on March 2019 to 42.9 on March 2024 . This represents a CAGR of -9.75% over 6 years.
  • The Latest Trading Price of Kilitch Drugs (India) Ltd is ₹ 326.35 as of 13 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Kilitch Drugs (India) Ltd

No data available

Company Fundamentals for Kilitch Drugs (India) Ltd

No data available

Image

Kilitch Drugs (India) Ltd

NSE: KILITCH

Share Price

₹ 326.35

2.15 (0.66%)

stock direction

Last updated on: Dec 13, 2024

Market Price of Kilitch Drugs (India) Ltd

1M

1Y

3Y

5Y

Monitoring Kilitch Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Dec 2024326.35
12 Dec 2024324.2
11 Dec 2024327.25
10 Dec 2024326.9
09 Dec 2024333.7
06 Dec 2024337.8
05 Dec 2024339.85
04 Dec 2024332.85
03 Dec 2024323.6
02 Dec 2024314.15

SWOT Analysis Of Kilitch Drugs (India) Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Kilitch Drugs (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Kilitch Drugs (India) Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Kilitch Drugs (India) Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical Revenue of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical EBITDA of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Kilitch Drugs (India) Ltd

No data available

* All values are in crore

Historical Dividend Payout of Kilitch Drugs (India) Ltd

No data available

* All values are in %

About Kilitch Drugs (India) Ltd

  • Kilitch Drugs (India) Limited (KDIL) was incorporated in May, 1992 as a public limited company.
  • The Company is a pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.
  • The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia.
  • Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms of creating safe pharmaceutical solutions. The Company went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules,liquid orals, ointments, creams and injectables.

Kilitch Drugs (India) Ltd News Hub

News

Kilitch Drugs (India) consolidated net profit declines 60.12% in the June 2024 quarter

Net profit of Kilitch Drugs (India) declined 60.12% to Rs 1.34 crore in the quarter ended ...

Read more

2024-08-09 00:00:00

News

Kilitch Drugs (India) to conduct board meeting

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 8 Au...

Read more

2024-08-02 00:00:00

News

Kilitch Drugs (India) to convene AGM

Kilitch Drugs (India) announced that the 32th Annual General Meeting (AGM) of the company ...

Read more

2024-08-31 00:00:00

News

Kilitch Drugs (India) announces board meeting date

Kilitch Drugs (India) will hold a meeting of the Board of Directors of the Company on 12 N...

Read more

2024-11-05 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Kilitch Drugs (India) Ltd

What is the current PE Ratio of Kilitch Drugs (India) Ltd?

The Current PE Ratio of Kilitch Drugs (India) Ltd is 31.87 as on 14 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 14 Dec 2024.

What was the PE Ratio of Kilitch Drugs (India) Ltd last year?

The PE Ratio of Kilitch Drugs (India) Ltd was 20.8 last year, now the PE ratio is 31.87, showing a year-on-year growth of 53.2%.

What does the PE Ratio of Kilitch Drugs (India) Ltd indicate about its stock?

The PE Ratio of Kilitch Drugs (India) Ltd is 31.87. This ratio indicates that investors are willing to pay 31.87 times the earnings per share for each share of Kilitch Drugs (India) Ltd.

What is the PE Ratio Growth of Kilitch Drugs (India) Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Kilitch Drugs (India) Ltd grew by 53.2% whereas, the EPS ratio grew by 545.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions